Leading-Edge Research in Alzheimer's Disease
Nova Science Publishers Inc (Verlag)
978-1-60456-225-5 (ISBN)
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory problems and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk of developing it, improving the accuracy of diagnosis and the ability to identify those at risk, discovering, developing, and testing new treatments, and discovering treatments for behavioural problems in patients with AD. This book presents important research in the field from around the world.
Preface; Ultrastructural Abnormalities in Skin Fibroblasts from Alzheimer's Disease Patients; Alzheimer's Disease: New Frontiers for the XXI Century; The influence of polymorphisms in proinflammatory genes on amyloid and non-amyloid vascular pathologies in Alzheimer's disease; Studies on Chinese Herbal Medicines for Alzheimer's Disease; The Role of Alleles 4 and 2 of the APOE Gene and Cognitive Tests in the Early Conversion of Mild Cognitive Impairment to Alzheimer Dementia; How and Where Does AB Exert its Toxic Effects in Alzheimer's Disease?; Coexistence of Alzheimer's Disease with Creutzfeldt-Jakob Disease; Neuro-inflammation and Impairment of Glial Cell Regulation: Implications for the Pathogenesis of Alzheimer's Disease; Low Molecular Weight Glycosaminoglycans and Apoptosis: Potential Treatment of Neurodegenerative Disorders Including Alzheimer's Disease; The Role of Donepezil in the Treatment of Dementia in Alzheimer's Disease in Adults with Down Syndrome; Index.
Erscheint lt. Verlag | 1.12.2008 |
---|---|
Zusatzinfo | Illustrations |
Verlagsort | New York |
Sprache | englisch |
Maße | 260 x 180 mm |
Gewicht | 748 g |
Themenwelt | Medizin / Pharmazie ► Gesundheitswesen |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Geriatrie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie | |
ISBN-10 | 1-60456-225-0 / 1604562250 |
ISBN-13 | 978-1-60456-225-5 / 9781604562255 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich